You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/36364
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCalegari, Leonardo-
dc.contributor.authorGorenstein, Clarice-
dc.contributor.authorGentil, Valentim-
dc.contributor.authorPlaneta, Cleopatra da Silva-
dc.contributor.authorNunes-De-Souza, Ricardo Lutz-
dc.date.accessioned2014-05-20T15:26:09Z-
dc.date.accessioned2016-10-25T18:00:42Z-
dc.date.available2014-05-20T15:26:09Z-
dc.date.available2016-10-25T18:00:42Z-
dc.date.issued2007-08-01-
dc.identifierhttp://dx.doi.org/10.1248/bpb.30.1541-
dc.identifier.citationBiological & Pharmaceutical Bulletin. Tokyo: Pharmaceutical Soc Japan, v. 30, n. 8, p. 1541-1546, 2007.-
dc.identifier.issn0918-6158-
dc.identifier.urihttp://hdl.handle.net/11449/36364-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/36364-
dc.description.abstractLong-term treatment with clomipramine (CMI), a tricyclic antidepressant, induces food craving and body weight gain in patients. The present study investigated the effects of chronic treatment with CMI on total food intake, macronutrient selection, and body weight gain in rats. Male Wistar rats were maintained on a dietary self-selection regime with separate sources of protein, fat and carbohydrate. Animals received i.p. injections of CMI (0, 3, 10, 30 mg/kg) during 27 consecutive days. Food consumption and body weight were recorded daily and results were calculated as average of three consecutive days, namely during pre-treatment (3 d before pharmacological treatment), treatment (7th-9th; l6th-l8th and 25th-27th days), and post-treatment (28th-33rd days). Results showed that CMI (30 mg/kg) significantly decreased energy intake during all treatment period, an effect that was related to a decrease in both carbohydrate-rich diet intake and body weight gain. At dose of 3 mg/kg CMI increased the total energy intake in the 16th-18th days, suggesting an apparent biphasic effect of chronic treatment with CMI on caloric intake. Chronic administration with CMI (27 d) did not alter protein-rich or fat-rich diet consumption. The main result of this study indicated that chronic treatment with CMI decreases rather than increase food consumption and body weight gain in rats exposed to a macronutrient self-selection procedure.en
dc.format.extent1541-1546-
dc.language.isoeng-
dc.publisherPharmaceutical Soc Japan-
dc.sourceWeb of Science-
dc.subjectmacronutrient self-selectionpt
dc.subjectchronic treatmentpt
dc.subjectclomipraminept
dc.subjectcarbohydratept
dc.subjectfatpt
dc.subjectproteinpt
dc.subjectratpt
dc.titleEffect of chronic treatment with Clomipramine on food intake, macronutrient selection and body weight gain in ratsen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationSão Paulo State Univ, Sch Pharmaceut Sci, Pharmacol Lab, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUniv São Paulo, Inst Biomed Sci, Lab Neuropsychopharmacol, BR-05508900 São Paulo, Brazil-
dc.description.affiliationUniv São Paulo, Med Ctr, Dept & Inst Psychiat, BR-01060970 São Paulo, Brazil-
dc.description.affiliationUniv Estadual Paulista, UFSCar Convenio, Programa Pos Graduacao Ciências Fisiol, São Paulo, Brazil-
dc.description.affiliationUnespSão Paulo State Univ, Sch Pharmaceut Sci, Pharmacol Lab, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUnespUniv Estadual Paulista, UFSCar Convenio, Programa Pos Graduacao Ciências Fisiol, São Paulo, Brazil-
dc.identifier.doi10.1248/bpb.30.1541-
dc.identifier.wosWOS:000249363300033-
dc.rights.accessRightsAcesso restrito-
dc.identifier.fileWOS000249363300033.pdf-
dc.relation.ispartofBiological & Pharmaceutical Bulletin-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.